C

Clinical Trials of SWLA, LLC | Lake Charles, LA

Research site

(Unclaimed)

Location

600 Bayou Pines E, Suite B, Lake Charles, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Relamorelin

Ontamalimab

Mesalamine

INCB050465

Hydroxyurea

IW-1701

Tetrodotoxin

Olinciguat

LY2835219

RESET-272

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 26 total trials

A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain

To be eligible for the trial, subjects must have ongoing moderate to severe neuropathic pain related to a prior course of platinum and/or taxane chem...

Enrolling

Chemotherapy-induced Peripheral Neuropathy

Chemotherapy-induced Neuropathic Pain

Drug: Placebo

Drug: Tetrodotoxin

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age (RSVictory)

The main purposes of Part A of this study are to evaluate the safety, tolerability, and immunogenicity of mRNA-1345 coadministered with a seasonal in...

Active, not recruiting

Respiratory Syncytial Virus

Biological: Afluria® Quadrivalent

Biological: mRNA-1273.214

Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer (postMONARCH)

This study will evaluate the effect of adding abemaciclib to fulvestrant for the treatment of hormone receptor-positive (HR+), human epidermal growth...

Active, not recruiting

Breast Neoplasm

Neoplasm Metastasis

Drug: Fulvestrant

Drug: Placebo